ConductScience.org, home

Trial · NCT00235495

Trial comparisons20

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Albumin vs Saline: Number of Participants With a Stroke Specific Quality of Life Scale (SSQOL) Score of >=3Trial comparisons
Albumin vs Saline: Recurrent Ischemic Stroke Within 30 DaysTrial comparisons
Albumin vs Saline: Atrial Fibrillation Within 48 HoursTrial comparisons
Albumin vs Saline: Pulmonary Edema Within 48 HoursTrial comparisons
Albumin vs Saline: Death Within 30 DaysTrial comparisons
Albumin vs Saline: Number of Participants With a Favorable Outcome Per Modified Rankin Scare (mRS)Trial comparisons
Albumin vs Saline: Asymptomatic ICH Within 24 HoursTrial comparisons
Albumin vs Saline: Shortness of Breath Within 48 HoursTrial comparisons
Albumin vs Saline: Number of Participants With a NIHSS of 0-1 at 24 HoursTrial comparisons
Albumin vs Saline: Number of Participants With Neurological Deterioration Within 48 HoursTrial comparisons
Albumin vs Saline: Symptomatic Intracerebral Hemorrhage (ICH) Within 24 HoursTrial comparisons
Albumin vs Saline: The Number of Participants With a Score on the mRS of 0-2 at 90 Days.Trial comparisons
Albumin vs Saline: Number of Participants With an EuroQol (EQ-5D) Favorable Score < 0.78Trial comparisons
Albumin vs Saline: Number of Participants With a Composite Outcome of mRS 0-1 and/or NIHSS 0-1 and/or Decrease in NIHSS From Baseline by 10 or More PointsTrial comparisons
Albumin vs Saline: Number of Participants With a NIHSS 0-1 at 90 Days.Trial comparisons
Albumin vs Saline: The Number of Participants With Favorable Outcome Defined as National Institute of Health Stroke Scale (NIHSS) Score of 0-1 and/or Modified Rankin Scale (mRS) of 0-1.Trial comparisons
Albumin vs Saline: Death Within 90 DaysTrial comparisons
Albumin vs Saline: Neurological Death Within 7 DaysTrial comparisons
Albumin vs Saline: The Number of Participants With a Score on the mRS 0-1 at 90 Days.Trial comparisons
Albumin vs Saline: serious adverse eventsTrial comparisons

trials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00235495/comparisons